NCT06915714View on ClinicalTrials.gov

The Prognostic Value of PET/CT for Tumor Progression in Patients With Metastatic Hormone-sensitive Prostate Cancer

CompletedOBSERVATIONAL

Enrollment

45

Participants

Timeline

Start Date

June 2, 2024

Primary Completion Date

February 20, 2025

Study Completion Date

February 28, 2025

Conditions

Prostate Cancer Metastatic DiseasePET / CT

Trial Locations (1)

510080

First affiliated hospital, Sun Yat-sen univeristy, Guangzhou

All Listed Sponsors

lead

Sun Yat-sen University

OTHER